ArticleObesity surgery2025
Metabolic Bariatric Surgery in Older Patients: Is It Worth It? BARI-10-POL Study.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing prevalence of obesity and rising life expectancy have led to a growing need for metabolic bariatric surgery (MBS) in older patients. While short-term outcomes are well documented, there is limited data on long-term outcomes comparing younger and older patients. This study aims to analyze 10-year outcomes after primary bariatric surgery in patients under 30 and over 60 years of age. MATERIALS AND
methodsA retrospective, multicenter analysis was conducted as part of the BARI-10-POL project, including patients who underwent laparoscopic MBS in Poland between 2008 and 2014. Inclusion criteria were age under 30 or over 60 years at the time of surgery and at least 10 years of follow-up.
resultsA total of 49 younger and 46 older patients were included. The most common procedure in both groups was sleeve gastrectomy. The percentage of excess weight loss (%EWL) was 59.3% in the younger group and 60.2% in the older group (p = 0.671), with percentage of total weight loss (%TWL) of 21.6% and 20.5% (p = 0.726), respectively. Older patients had a higher prevalence of type 2 diabetes and hypertension, with remission rates of 52.8% and 40.5%, respectively, compared to 42.9% and 62.5% in younger patients (p = 0.302; p = 0.303). Complication rates were 2.0% in younger and 4.3% in the older group (p = 0.517), with no mortality observed in either group.
conclusionsMBS seems to be effective and safe in long-term follow-up across different age groups. There were no statistical differences in weight loss or metabolic outcomes between younger and older patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.